Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NURO 1.15
price chart
NeuroMetrix, Inc. Announces Date for 2015 First Quarter Financial Results ...
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2015 first quarter financial results before the opening of the market on April 21, 2015.
GE Announces 2015 First-Quarter Results  Finances.com
NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 ...
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.
Related articles »  
NeuroMetrix Inc.: NeuroMetrix Reports Q1 2015 Financial Results and Highlights
"I'm pleased with the substantial progress we've made throughout the Company, both with DPNCheck and toward a second quarter Quell launch target," said Shai N. Gozani, M.D.
NeuroMetrix's (NURO) CEO Dr. Shai Gozani on Q1 2015 Results - Earnings ...  Seeking Alpha
Neurometrix Inc (NURO): Is NeuroMetrix A Good Buy?
NeuroMetrix (NASDAQ:NURO) is a medical device company that develops and markets devices for the treatment and management of the neurological complications of diabetes.
Kenneth J. Snow, M.D., Chief Medical Officer of NeuroMetrix, Inc. Interviewed ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that its Chief Medical Officer ...
NeuroMetrix Skyrockets On FDA Approval For Its Wearable Device
NeuroMetrix Inc. (NURO) soared over 30% after the Food and Drug Administration (FDA) approved the company's pain relieving wearable device for over-the-counter sale in the US.
NeuroMetrix gets clearance to market an over-the-counter pain management ...  Boston Globe
With consumer product, NeuroMetrix CEO says he'll need to open a new ...  Boston Business Journal (blog)
Related articles »  
Investors Are Watching: NeuroMetrix Inc. (NASDAQ:NURO), CONE Midstream ...
NeuroMetrix Inc. (NASDAQ:NURO) belongs to Healthcare sector. Its weekly performance is 21.42%. On last trading day company shares ended up $1.36.
Sabby Management Buys 3 Biotech Stocks
Traders may want to take note of holdings disclosed by Sabby Management LLC to the SEC on Thursday. The firm reported 9.99 percent ownership stakes in the following biotech companies: Neurometrix Inc (NASDAQ: NURO) is a medical device company ...
The Future Of NeuroMetrix
NeuroMetrix was once a Robin Hood story: the company stole from the neurologists, gave to the family practitioners, and made awesome margins in doing so.
Most Volatile Stocks: NeuroMetrix Inc. (NURO), Centrais Eletricas Brasileiras ...
NeuroMetrix Inc. (NURO) of the Healthcare sector has lost -4.71% from opening today with a volume of 20,451 shares and volatility of 12.14%.